267 related articles for article (PubMed ID: 1465828)
1. Influence of HLA matching on the outcome of kidney transplants in a single center analysis.
Schanz D; Blümke M; Keller E; Tanzi-Fetta RF; Kirste G
Transplant Proc; 1992 Dec; 24(6):2455. PubMed ID: 1465828
[No Abstract] [Full Text] [Related]
2. Repeated mismatches may not impair survival of renal regrafts in recipients with 0% to 50% panel reactive antibodies.
Mjörnstedt L; Konar J; Skarp I; Olausson M; Sandberg L; Tufvesson G
Transplant Proc; 1992 Dec; 24(6):2469. PubMed ID: 1465834
[No Abstract] [Full Text] [Related]
3. Influence of HLA antigens of renal transplant recipients on graft survival.
Alamartine E; Berthoux F; Acquart S; Lepetit JC
Transplant Proc; 1992 Dec; 24(6):2461-2. PubMed ID: 1465831
[No Abstract] [Full Text] [Related]
4. Repeated HLA mismatch in multiple kidney transplantation: preliminary results of 146 retransplantations in the cyclosporine era.
Gnant MF; Sautner T; Rosenmayr A; Muehlbacher F
Transplant Proc; 1992 Dec; 24(6):2466-8. PubMed ID: 1465833
[No Abstract] [Full Text] [Related]
5. Critical importance of HLA antigen matching in cadaveric kidney transplantation with high overall survival rates. The Manchester UK Kidney Transplant Team.
Dyer PA; Martin S; Johnson RW
Transplant Proc; 1992 Dec; 24(6):2454. PubMed ID: 1465827
[No Abstract] [Full Text] [Related]
6. Quality of serological donor HLA typing: analysis of graft survival by HLA in renal transplantation recipients treated with cyclosporine.
Thorogood J; Schreuder GM; Persijn GG; van Rood JJ
Transplant Proc; 1992 Dec; 24(6):2485-7. PubMed ID: 1465839
[No Abstract] [Full Text] [Related]
7. Beneficial effect of DR matching on cadaveric renal graft survival in Scandiatransplant.
Leivestad T; Berger L; Thorsby E
Transplant Proc; 1992 Dec; 24(6):2447-8. PubMed ID: 1465824
[No Abstract] [Full Text] [Related]
8. Influence of recipient's HLA type on the outcome of renal transplantation.
Forsberg B; Ekberg H; Johnson U
Transplant Proc; 1992 Dec; 24(6):2463-5. PubMed ID: 1465832
[No Abstract] [Full Text] [Related]
9. Single center experience with the CTS-HIT allocation system for highly immunized patients. The Leuven Collaborative Group for Transplantation.
Roels L; Vanrenterghem Y; Waer M; Dendievel J; Emonds MP; Christiaens R; Gruwez J; Michielsen P
Transplant Proc; 1992 Dec; 24(6):2492-3. PubMed ID: 1465841
[No Abstract] [Full Text] [Related]
10. Cold ischemia time and MHC class II matching in renal transplants.
Iwaki Y; Cicciarelli J; Aswad S; Gavazov M; Obispo E; Khetan U; Bogaard T; Asai P; Mendez RG; Mendez R
Transplant Proc; 1992 Dec; 24(6):2456-7. PubMed ID: 1465829
[No Abstract] [Full Text] [Related]
11. Negative crossmatch on current sera and good HLA matching are the main requirements for renal transplantation in highly sensitized patients.
Cristol JP; Mourad G; Argiles A; Seignalet J; Iborra F; Ramounau-Pigot A; Chong G; Mion C
Transplant Proc; 1992 Dec; 24(6):2470-1. PubMed ID: 1465835
[No Abstract] [Full Text] [Related]
12. The graft survival curve: ideology and rhetoric.
Guttmann RD
Transplant Proc; 1992 Dec; 24(6):2407-10. PubMed ID: 1465810
[No Abstract] [Full Text] [Related]
13. HLA-DR matching and anti-donor-specific antibodies in kidney transplant recipients.
Valeri M; Piazza A; Torlone N; Poggi E; Monaco PI; Provenzani L; Adorno D; Casciani CU
Transplant Proc; 1992 Dec; 24(6):2514-6. PubMed ID: 1465850
[No Abstract] [Full Text] [Related]
14. Six-year experience with a triple drug protocol in renal transplantation: analysis of risk factors.
Pallardó LM; Sánchez P; Sánchez J; García J; Orero E; Beneyto I; Cruz JM
Transplant Proc; 1992 Dec; 24(6):2714-5. PubMed ID: 1465911
[No Abstract] [Full Text] [Related]
15. HLA-A, B, DR antigens and renal transplantation from cadaveric donors and living-related donors in Greek patients.
Adam K; Polymenidis Z; Papakyriazi L; Alexopoulos E; Parapanissiou E; Antoniadis A; Papadimitriou M
Transplant Proc; 1992 Dec; 24(6):2449-50. PubMed ID: 1465825
[No Abstract] [Full Text] [Related]
16. HLA matching in liver transplantation: a retrospective analysis.
Gunson BK; Hathaway M; Buckels JA; Mayer AD; Elias E; McMaster P; Neuberger JM
Transplant Proc; 1992 Dec; 24(6):2434-5. PubMed ID: 1465819
[No Abstract] [Full Text] [Related]
17. Reliability of HLA typing on peripheral blood lymphocytes in cadaveric organ donors and the impact of blank donor antigens on kidney graft survival.
Offermann G; Bünte S; Angelides U; Geidner U; Kirschbaum B; Müller E; Wendt N
Transplant Proc; 1992 Dec; 24(6):2488-9. PubMed ID: 1361261
[No Abstract] [Full Text] [Related]
18. Matching for HLA-DPB1 alleles in zero mismatched HLA-A, -B, and -DR renal transplants.
Middleton D; Mytilineos Y; Savage D; Ferrara GB; Angelini G; Amoroso A; Trainor F; Gaweco A; Mazzola G; Delfino L
Transplant Proc; 1992 Dec; 24(6):2439-40. PubMed ID: 1361255
[No Abstract] [Full Text] [Related]
19. Effect of anti-HLA and anti-idiotypic antibodies on the long-term survival of heart and kidney allografts.
Reed E; Cohen DJ; Barr ML; Ho E; Marboe CC; Rose EA; Hardy M; Suciu-Foca N
Transplant Proc; 1992 Dec; 24(6):2494-5. PubMed ID: 1465842
[TBL] [Abstract][Full Text] [Related]
20. HLA-DR matching defined by SSO-typing in heart transplantation.
Poli F; Scalamogna M; Pappalettera M; Mascaretti L; Nocco A; Crespiatico L; Sirchia G
Transplant Proc; 1992 Dec; 24(6):2436-7. PubMed ID: 1465820
[No Abstract] [Full Text] [Related]
[Next] [New Search]